Medicinal product name Spinraza
Pharmaceutical form Solution for injection
Strength 12 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/17/1188/001 KZSN1 Is available
Legal status Rx Prescription (Pr.)
KZS NHS Reimbursed medicines
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Conclusion on the therapeutic and cost effectiveness of medicines Oct 17, 2022 G12.1
ATC code M09AX07 Other drugs for disorders of the musculo-skeletal system

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(2 containers)
Tamro N1
(12 mg/5 ml)
Glass vial 101644.30 
KZS*
EU/1/17/1188/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/17/1188/001
Date of authorisation May 30, 2017
Marketing authorisation holder, country Biogen Netherlands B.V., Netherlands